Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 03, 2015 8:37 PM ET

Healthcare Providers and Services

Company Overview of Genelex Corporation

Company Overview

Genelex Corporation operates as a DNA testing laboratory. It provides a program for personalized medication management consisting of DNA sensitivity testing, as well as GeneMedRx software, a software tool that predicts potential drug-drug and drug-gene interaction risk based on cytochrome P450 metabolism and genetic testing for interpreting the test results based on all of the medicines a patient is taking. The company offers services, such as parentage and forensic DNA testing, pharmacogenetic testing, ancestry DNA testing, clinical trial genotyping services, and predicitive genetic testing. Genelex Corporation, through its online store, also offers various at-home or legally admissible DNA...

3000 First Avenue

Suite One

Seattle, WA 98121

United States

Founded in 1987

Phone:

206-382-9591

Fax:

206-219-4000

Key Executives for Genelex Corporation

Co-founder, Chairman of the Board and Chief Executive Officer
Co-founder, Chief Science Officer and Director
Chief Operating Officer
Executive Vice President and Director
Chief Information Officer
Compensation as of Fiscal Year 2014.

Genelex Corporation Key Developments

Genelex Corporation Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 03:25 PM

Genelex Corporation Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 03:25 PM. Venue: Washington State Convention Center, Seattle, Washington, United States.

Genetic Technologies Limited Announces Settlement and Release Agreement with Genelex Corporation

Genetic Technologies Limited reported it has now executed a settlement and release agreement with Genelex Corporation. In late 2012, GTG reported that it had filed suit against Genelex Corporation in the United States District Court for the Western District of Washington at Seattle, under its Assertion program in USA. Given the Parties have now reached a final settlement, such legal action against Genelex Corporation is now being dismissed. This settlement was achieved as a result of GTG's continuing patent monetization efforts in the US and other jurisdictions.

Similar Private Companies By Industry

Company Name Region
Methodist McKinney Surgery Center United States
Cascade Healthcare Services LLC United States
Suncoast Imaging Partners, P.A. United States
Crossroads Regional Hospital, LLC United States
SwedishAmerican Health System Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genelex Corporation, please visit www.genelex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.